In the role of a dual-action medication, Mounjaro (tirzepatide) activates both GLP-1 and GIP receptors, enhancing insulin secretion while lowering glucagon levels
Similarly, restarting semaglutide after a break often involves a brief stall period as the medication rebuilds blood levels and begins re-engaging appetite circuits
This may mean reducing your caloric intake again by a small amount
Methods Adults with T2D treated with 2 glucose-lowering agents who initiated GLP-1 RAs or basal insulin from 2010 to 2019 were propensity-score matched (1:1) and followed until October 2021 (intention-to-treat [ITT])
Until the research catches up, its best to use GLP-1s under the guidance of qualified physicians for approved indications (conditions like type 2 diabetes, obesity, and sleep apnea)
On the innervation of the ileal mucosa in the rata synapse